Aspen Aerogels Inc. (ASPN)
Aspen Aerogels Statistics
Share Statistics
Aspen Aerogels has 82.1M shares outstanding. The number of shares has increased by 7.8% in one year.
Shares Outstanding | 82.1M |
Shares Change (YoY) | 7.8% |
Shares Change (QoQ) | 0.07% |
Owned by Institutions (%) | 95.69% |
Shares Floating | 80.69M |
Failed to Deliver (FTD) Shares | 6 |
FTD / Avg. Volume | < 0.01% |
Short Selling Information
The latest short interest is 9.13M, so 11.12% of the outstanding shares have been sold short.
Short Interest | 9.13M |
Short % of Shares Out | 11.12% |
Short % of Float | 13.3% |
Short Ratio (days to cover) | 4.46 |
Valuation Ratios
The PE ratio is 68.87 and the forward PE ratio is 9.31. Aspen Aerogels's PEG ratio is -0.55.
PE Ratio | 68.87 |
Forward PE | 9.31 |
PS Ratio | 2.03 |
Forward PS | 0.4 |
PB Ratio | 1.5 |
P/FCF Ratio | -22.62 |
PEG Ratio | -0.55 |
Enterprise Valuation
Aspen Aerogels has an Enterprise Value (EV) of 802.66M.
EV / Sales | 1.77 |
EV / EBITDA | 16.19 |
EV / EBIT | 17.62 |
EV / FCF | -19.72 |
Financial Position
The company has a current ratio of 3.72, with a Debt / Equity ratio of 0.17.
Current Ratio | 3.72 |
Quick Ratio | 3.29 |
Debt / Equity | 0.17 |
Debt / EBITDA | 2.07 |
Debt / FCF | -2.52 |
Interest Coverage | 4.56 |
Financial Efficiency
Return on Equity is 2.18% and Return on Invested Capital is 5.95%.
Return on Equity | 2.18% |
Return on Assets | 1.49% |
Return on Invested Capital | 5.95% |
Revenue Per Employee | $817.15K |
Profits Per Employee | $24.14K |
Employee Count | 554 |
Asset Turnover | 0.51 |
Inventory Turnover | 5.67 |
Taxes
Income Tax | 1.71M |
Effective Tax Rate | 11.36% |
Stock Price Statistics
The stock price has increased by -64.52% in the last 52 weeks. The beta is 2.35, so Aspen Aerogels's price volatility has been higher than the market average.
Beta | 2.35 |
52-Week Price Change | -64.52% |
50-Day Moving Average | 6.55 |
200-Day Moving Average | 15.82 |
Relative Strength Index (RSI) | 39.08 |
Average Volume (20 Days) | 1.97M |
Income Statement
In the last 12 months, Aspen Aerogels had revenue of 452.7M and earned 13.38M in profits. Earnings per share was 0.17.
Revenue | 452.7M |
Gross Profit | 182.9M |
Operating Income | 54.53M |
Net Income | 13.38M |
EBITDA | 49.57M |
EBIT | 27.05M |
Earnings Per Share (EPS) | 0.17 |
Balance Sheet
The company has 220.88M in cash and 102.42M in debt, giving a net cash position of 118.46M.
Cash & Cash Equivalents | 220.88M |
Total Debt | 102.42M |
Net Cash | 118.46M |
Retained Earnings | -660.23M |
Total Assets | 895.14M |
Working Capital | 299.34M |
Cash Flow
In the last 12 months, operating cash flow was 45.55M and capital expenditures -86.26M, giving a free cash flow of -40.71M.
Operating Cash Flow | 45.55M |
Capital Expenditures | -86.26M |
Free Cash Flow | -40.71M |
FCF Per Share | -0.53 |
Margins
Gross margin is 40.4%, with operating and profit margins of 12.05% and 2.95%.
Gross Margin | 40.4% |
Operating Margin | 12.05% |
Pretax Margin | 3.33% |
Profit Margin | 2.95% |
EBITDA Margin | 10.95% |
EBIT Margin | 12.05% |
FCF Margin | -8.99% |
Dividends & Yields
ASPN does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | 1.45% |
FCF Yield | -4.42% |
Analyst Forecast
The average price target for ASPN is $18, which is 233.3% higher than the current price. The consensus rating is "Buy".
Price Target | $18 |
Price Target Difference | 233.3% |
Analyst Consensus | Buy |
Analyst Count | 10 |
Scores
Altman Z-Score | 2.32 |
Piotroski F-Score | 8 |